BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8421432)

  • 1. Effects of in vivo morphine treatment on antibody responses in C57BL/6 bgJ/bgJ (beige) mice.
    Bussiere JL; Adler MW; Rogers TJ; Eisenstein TK
    Life Sci; 1993; 52(4):PL43-8. PubMed ID: 8421432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive effects of morphine on immune responses in mice.
    Eisenstein TK; Bussiere JL; Rogers TJ; Adler MW
    Adv Exp Med Biol; 1993; 335():41-52. PubMed ID: 8237606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of morphine and naltrexone on the antibody response in various mouse strains.
    Bussiere JL; Adler MW; Rogers TJ; Eisenstein TK
    Immunopharmacol Immunotoxicol; 1992; 14(3):657-73. PubMed ID: 1517538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The analgesic defect of C57BL/6J-bgJ/bgJ (beige-J: Chediak-Higashi syndrome) mice transmitted by adoptive transfer of spleen cells to normal littermates.
    Raffa RB; Kimball ES; Mathiasen JR
    Life Sci; 1988; 42(12):1231-6. PubMed ID: 3347148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of analgesic response of C57BL/6J-bgJ (beige-J) mice to morphine by carbachol.
    Raffa RB; Mathiasen JR; Vaught JL
    Eur J Pharmacol; 1987 Sep; 141(3):507-10. PubMed ID: 3666044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C57BL/6J-bgJ (beige) mice: differential sensitivity in the tail flick test to centrally administered mu- and delta-opioid receptor agonists.
    Mathiasen JR; Raffa RB; Vaught JL
    Life Sci; 1987 May; 40(20):1989-94. PubMed ID: 3033418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinociceptive and antitussive effects of morphine in the DA-bg/bg (beige) rat.
    Kamei J; Morita K; Saitoh A; Suzuki T; Nagase H
    Eur J Pharmacol; 1996 Apr; 300(1-2):75-8. PubMed ID: 8741168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinociceptive defect of beige-J mice reversed by i.c.v. IP3 or myo-inositol.
    Raffa RB; Martinez RP
    Neuroreport; 1995 Jul; 6(10):1434-6. PubMed ID: 7488742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective cytoplasmic granule formation. I. Abnormalities affecting tissue mast cells and pancreatic acinar cells of beige mice.
    Hammel I; Dvorak AM; Galli SJ
    Lab Invest; 1987 Mar; 56(3):321-8. PubMed ID: 3821071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressive effects of morphine pellet implants on in vivo parameters of immune function.
    Bryant HU; Roudebush RE
    J Pharmacol Exp Ther; 1990 Nov; 255(2):410-4. PubMed ID: 2243332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphine-induced decreases in in vivo antibody responses.
    Lockwood LL; Silbert LH; Fleshner M; Laudenslager ML; Watkins LR; Maier SF
    Brain Behav Immun; 1994 Mar; 8(1):24-36. PubMed ID: 8003769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The accumulation and metabolism of glycosphingolipids in primary kidney cell cultures from beige mice.
    Gross SK; Lyerla TA; Williams MA; McCluer RH
    Mol Cell Biochem; 1992 Dec; 118(1):61-6. PubMed ID: 1488056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulatory activity of mu- and kappa-selective opioid agonists.
    Taub DD; Eisenstein TK; Geller EB; Adler MW; Rogers TJ
    Proc Natl Acad Sci U S A; 1991 Jan; 88(2):360-4. PubMed ID: 1846441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obligatory role of B cells and adherent accessory cells in the transfer of a defect in morphine-mediated antinociception in C57BL/6J-bg/bg (beige-J) mice.
    Kimball ES; Raffa RB
    J Neuroimmunol; 1989 May; 22(3):185-92. PubMed ID: 2784797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quaternary naltrexone reverses morphine-induced behaviors.
    Mickley GA; Stevens KE; Galbraith JA
    Physiol Behav; 1985 Aug; 35(2):249-53. PubMed ID: 4070392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naltrexone antagonizes the analgesic and immunosuppressive effects of morphine in mice.
    Carr DJ; Gerak LR; France CP
    J Pharmacol Exp Ther; 1994 May; 269(2):693-8. PubMed ID: 8182537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous development of opioid tolerance and opioid antagonist-induced receptor upregulation.
    Yoburn BC; Sierra V; Lutfy K
    Brain Res; 1990 Oct; 529(1-2):143-8. PubMed ID: 2178026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different effects of dimethylbenz(alpha)anthracene and tetradecanoylphorbol acetate on differentiation of mast cells in the skin of mice.
    Sonoda T; Tsuyama K; Kitamura Y; Tanooka H
    Am J Pathol; 1982 Mar; 106(3):312-7. PubMed ID: 6801988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine reversal of morphine-induced suppression of the antibody response.
    Bussiere JL; Adler MW; Rogers TJ; Eisenstein TK
    J Pharmacol Exp Ther; 1993 Feb; 264(2):591-7. PubMed ID: 8437110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphine-induced suppression of cytotoxic T lymphocyte activity in alloimmunized mice is not mediated through a naltrindole-sensitive delta opioid receptor.
    Carr DJ; Carpenter GW
    Neuroimmunomodulation; 1995; 2(1):44-53. PubMed ID: 7614260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.